The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

spinalrestoration.com

Total Raised

$25M

Investors Count

5

Deal Terms

1

Spinal Restoration Funding, Spinal Restoration Valuation & Spinal Restoration Revenue

5 Fundings

Spinal Restoration's latest funding round was a Series E for on June 7, 2013.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/7/2013

Series E

Undisclosed Investors

0

FY undefined

10/22/2012

Line of Credit

$99M

0

FY undefined

0

10/22/2012

Series D

$99M

0

FY undefined

10

3/17/2010

Series C

$99M

0

FY undefined

0

10/12/2007

Series B

$99M

0

FY undefined

0

Date

6/7/2013

10/22/2012

10/22/2012

3/17/2010

10/12/2007

Round

Series E

Line of Credit

Series D

Series C

Series B

Amount

$99M

$99M

$99M

$99M

Investors

Undisclosed Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

0

10

0

0

Spinal Restoration Deal Terms

1 Deal Term

Spinal Restoration's deal structure is available for 1 funding round, including their Series B from October 12, 2007.

Round

Series B

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Spinal Restoration Investors

5 Investors

Spinal Restoration has 5 investors. Austin Ventures invested in Spinal Restoration's Series D funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/12/2007

10/22/2012

3
Series B, Series C (2010), Series D (2012)

Venture Capital

Texas

00/00/0000

00/00/0000

Sante

Subscribe to see more

Venture Capital

Texas

00/00/0000

00/00/0000

MB Venture Partners

Subscribe to see more

Venture Capital

Tennessee

00/00/0000

00/00/0000

Comerica

Subscribe to see more

Bank

Texas

00/00/0000

00/00/0000

Path4 Ventures

Subscribe to see more

Subscribe to see more

Venture Capital

Texas

First funding

10/12/2007

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

10/22/2012

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Sante

MB Venture Partners

Comerica

Path4 Ventures

Rounds

3
Series B, Series C (2010), Series D (2012)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Venture Capital

Venture Capital

Venture Capital

Bank

Venture Capital

Location

Texas

Texas

Tennessee

Texas

Texas

You May Also Like

D
Disc Dynamics

Disc Dynamics has developed the DASCORTM Disc Arthroplasty System, an innovative, minimally invasive nucleus replacement treatment for patients suffering from chronic low back pain caused by Degenerative Disc Disease (DDD).

MicroTransponder Logo
MicroTransponder

MicroTransponder develops a wireless neurostimulation system for the treatment of chronic pain and several other neurological indications. The minimally invasive device will provide relief from chronic pain without requiring an implanted battery or wires. The Company is finishing R&D on the device and accumulating data toward FDA clearance. MicroTransponder is also adapting the company's system for Vagus Nerve Stimulation to create a pipeline of treatments for other neurological indications, including stroke rehabilitation, tinnitus, and autism.

A
Axial Biotech

Axial Biotech, founded in 2002 by a group of spine surgeons and geneticists, is focused on the use of genetics and the development of minimally invasive fusionless devices to advance the diagnosis and treatment of diseases and deformities of the human spine. Axial is a company to pursue DNA-based pre-symptomatic and prognostic tests for common spinal conditions which will augment current clinical and surgical practices. In its initial genetic product development initiative, Axial has made progress towards the discovery of a location in the human genome that is associated with adolescent idiopathic scoliosis. In addition, Axial's founders have developed five motion preserving, fusionless surgical devices (including such device currently being implanted in humans) that have the promise of expanding the current treatable scoliosis patient population by a factor of ten. Axial intends to use its genetic intellectual property in the development of bio-mechanical devices, and to apply its gene discovery/product development methodology to other spinal diseases. Axial (www.axialbiotech.com) is located in Salt Lake City, Utah.

B
Biospiral

BioSpiral's state-of-art system aims to provide prostate cancer treatment as a minimally invasive procedure, which uses cooling & heating technologies to destroy prostate cancer.nBioSpiral was established in Sep 2006 and is operating as part of NGT Incubator. nBioSpiral prostate thermodynamics therapy is an effective, minimally invasive treatment for prostate cancer that does not involve the difficulty and complications associated with surgery, nor the harmful properties of radiation or cryotherapy .The system revolutionizes prostate cancer treatment by introducing a "one shot" treatment method under local anesthesia at the physician's clinic. BioSpiral treatment is for patients with localized prostate cancer, who look for an effective minimal invasive therapy for prostate cancer. Additionally, this treatment can also be used by patients who have local recurrence after other treatments ("salvage" treatment). Key advantages:nCost effective: short treatment, no need for O.R or hospitalizationnHighly efficient: tissue ablationnPatients: high quality of life; minimal side effects, minimal invasive, short treatment & recovery.

S
Simpirica Spine

Simpirica is developing a dynamic stabilization system designed to stabilize the spine in flexion and help patients return to more healthy, active lifestyles. The company's lead product, the LimiFlex Spinal Stabilization System, is typically used in conjunction with a surgical decompression for the treatment of lumbar spinal stenosis with or without degenerative spondylolisthesis.

Spine Wave Logo
Spine Wave

Spine Wave is developing a procedure for treating back pain and other spinal conditions by restoring the function of the spinal disc. The procedure uses an injectable protein-based formulation for the repair of spinal discs damaged either by injury or aging.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.